Evaluation of choroidal thickness in psoriasis using optical coherence tomography
Fatih Mehmet Türkcü1, Alparslan Şahin2, Harun Yüksel2
1Department of Ophthalmology, Dicle University Faculty of Medicine, Diyarbakir, Turkey. turkcufm@gmail.com.
Psoriasis patients show increased choroidal thickness (CT) compared to healthy individuals, as measured by enhanced depth imaging optical coherence tomography (EDI-OCT). This study found no correlation between CT and psoriasis activity or duration.
Area of Science:
- Ophthalmology
- Dermatology
- Medical Imaging
Background:
- Psoriasis is a chronic inflammatory disease with potential systemic manifestations.
- Ocular involvement in psoriasis, such as uveitis, is known.
- Choroidal thickness (CT) is a potential biomarker for inflammatory conditions.
Purpose of the Study:
- To evaluate choroidal thickness (CT) in patients with psoriasis.
- To compare CT in psoriasis patients versus healthy controls.
- To determine the relationship between CT and psoriasis activity indices.
Main Methods:
- Prospective study involving 35 psoriasis patients and 30 healthy controls.
- Enhanced depth imaging optical coherence tomography (EDI-OCT) for CT measurement in the subfoveal area.
- Correlation analysis with disease duration and clinical disease activity score.
Main Results:
- Choroidal thickness (CT) was significantly higher in psoriasis patients compared to controls (p < 0.001).
- Central foveal thickness was comparable between groups (p = 0.672).
- No significant correlation was found between CT, disease activity score, and disease duration (p < 0.05).
Conclusions:
- Psoriasis patients exhibit increased choroidal thickness.
- EDI-OCT may help understand ocular effects and pathophysiology of psoriasis.
- Further large-scale studies are needed to confirm these findings.
More Related Videos
03:47Retinal and Choroidal Thickness Changes in Populations with Helicobacter pylori Infection by Swept-Source Optical Coherence Tomography
Published on: November 1, 2024
06:15Author Spotlight: Anterior HR-OCT as a Non-Invasive Tool for Characterizing Ocular Surface Squamous Neoplasia
Published on: August 9, 2024
